These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Hoffman IE, Lauwerys BR, De Keyser F, Huizinga TW, Isenberg D, Cebecauer L, Dehoorne J, Joos R, Hendrickx G, Houssiau F, Elewaut D. Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995 [Abstract] [Full Text] [Related]
23. The HLA profiles of mixed connective tissue disease differ distinctly from the profiles of clinically related connective tissue diseases. Flåm ST, Gunnarsson R, Garen T, Norwegian MCTD Study Group, Lie BA, Molberg Ø. Rheumatology (Oxford); 2015 Mar; 54(3):528-35. PubMed ID: 25187641 [Abstract] [Full Text] [Related]
24. Clinical significance of antibodies to a 68 kDa U1RNP polypeptide in connective tissue disease. McHugh N, James I, Maddison P. J Rheumatol; 1990 Oct; 17(10):1320-8. PubMed ID: 1701488 [Abstract] [Full Text] [Related]
25. "To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity. Cappelli S, Bellando Randone S, Martinović D, Tamas MM, Pasalić K, Allanore Y, Mosca M, Talarico R, Opris D, Kiss CG, Tausche AK, Cardarelli S, Riccieri V, Koneva O, Cuomo G, Becker MO, Sulli A, Guiducci S, Radić M, Bombardieri S, Aringer M, Cozzi F, Valesini G, Ananyeva L, Valentini G, Riemekasten G, Cutolo M, Ionescu R, Czirják L, Damjanov N, Rednic S, Matucci Cerinic M. Semin Arthritis Rheum; 2012 Feb; 41(4):589-98. PubMed ID: 21959290 [Abstract] [Full Text] [Related]
27. Histological analysis of esophageal muscular layers from 27 autopsy cases with mixed connective tissue disease (MCTD). Uzuki M, Kamataki A, Watanabe M, Sasaki N, Miura Y, Sawai T. Pathol Res Pract; 2011 Jun 15; 207(6):383-90. PubMed ID: 21620578 [Abstract] [Full Text] [Related]
29. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Jais X, Launay D, Yaici A, Le Pavec J, Tchérakian C, Sitbon O, Simonneau G, Humbert M. Arthritis Rheum; 2008 Feb 15; 58(2):521-31. PubMed ID: 18240255 [Abstract] [Full Text] [Related]
30. Nailfold capillary density as a possible indicator of pulmonary capillary loss in systemic lupus erythematosus but not in mixed connective tissue disease. Pallis M, Hopkinson N, Powell R. J Rheumatol; 1991 Oct 15; 18(10):1532-6. PubMed ID: 1765978 [Abstract] [Full Text] [Related]
31. [Clinical study of interstitial lung disease in mixed connective tissue disease]. Colin G, Nunes H, Hatron PY, Cadranel J, Tillie I, Wallaert B. Rev Mal Respir; 2010 Mar 15; 27(3):238-46. PubMed ID: 20359616 [Abstract] [Full Text] [Related]
32. Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease. Bertoli AM, Alarcón GS, Calvo-Alén J, Fernández M, Vilá LM, Reveille JD, LUMINA Study Group. Arthritis Rheum; 2006 May 15; 54(5):1580-7. PubMed ID: 16645994 [Abstract] [Full Text] [Related]
33. Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes. Pluchinotta FR, Schiavo B, Vittadello F, Martini G, Perilongo G, Zulian F. Lupus; 2007 May 15; 16(8):550-5. PubMed ID: 17711887 [Abstract] [Full Text] [Related]
35. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L, Bach JF, Piette JC. Arthritis Rheum; 2000 Jan 15; 43(1):76-84. PubMed ID: 10643702 [Abstract] [Full Text] [Related]
36. [The Sharp syndrome ("mixed connective tissue disease")]. Rosenthal M. Schweiz Med Wochenschr; 1976 Jan 31; 106(5):129-34. PubMed ID: 1082643 [Abstract] [Full Text] [Related]
37. Clinical course, prognosis, and causes of death in mixed connective tissue disease. Hajas A, Szodoray P, Nakken B, Gaal J, Zöld E, Laczik R, Demeter N, Nagy G, Szekanecz Z, Zeher M, Szegedi G, Bodolay E. J Rheumatol; 2013 Jul 31; 40(7):1134-42. PubMed ID: 23637328 [Abstract] [Full Text] [Related]
38. Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases. Mitsuo A, Morimoto S, Nakiri Y, Suzuki J, Kaneko H, Tokano Y, Tsuda H, Takasaki Y, Hashimoto H. Rheumatology (Oxford); 2006 Dec 31; 45(12):1477-84. PubMed ID: 16638798 [Abstract] [Full Text] [Related]
39. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary--clinical characteristics and disease course of 44 patients with juvenile dermatomyositis. Constantin T, Ponyi A, Orbán I, Molnár K, Dérfalvi B, Dicso F, Kálovics T, Müller J, Garami M, Sallai A, Balogh Z, Szalai Z, Fekete G, Dankó K. Autoimmunity; 2006 May 31; 39(3):223-32. PubMed ID: 16769656 [Abstract] [Full Text] [Related]
40. Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease. Ikeda K, Takasaki Y, Hirokawa K, Takeuchi K, Hashimoto H. J Rheumatol; 2003 May 31; 30(5):998-1005. PubMed ID: 12734895 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]